Screener
Diebold Nixdorf DBD Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $7.1M-83.0% | $16.2M+27.6% | $5.5M+173% | $50.5M— | $41.7M+292% | ||
| $31.5M-0.6% | $30.8M-41.6% | $31.4M+153% | $30.7M+115% | $31.7M+199% | ||
| $4.3M+43.3% | $4.2M+27.3% | $3.2M+6.7% | $2.8M+21.7% | $3M+3.4% | ||
| -$47.4M-227% | —— | $31.7M+102% | $217.5M+10.9% | $37.4M+341% | ||
| -$13.2M+49.6% | —— | $20.2M— | -$38.6M-123% | -$26.2M-111% | ||
| $33.9M-15.0% | $60.6M+101% | $60.4M+529% | $51.1M+2,122% | $39.9M+3,527% | ||
| -$36M+18.4% | -$62.5M-99.7% | -$62.2M-386% | -$55.7M+71.0% | -$44.1M-859% | ||
| -$97.5M-199% | -$91.2M-265% | -$13.7M-254% | $124.7M+640% | -$32.6M-26.8% |
FAQ
- Where does Diebold Nixdorf's cash flow data come from?
- Every line is extracted from Diebold Nixdorf's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
